Renal Dysfunction in Patients With Direct Infiltration by B-Cell Lymphoma.

acute kidney injury kidney biopsy renal lymphoma

Journal

Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752

Informations de publication

Date de publication:
May 2019
Historique:
received: 21 11 2018
revised: 28 01 2019
accepted: 04 02 2019
entrez: 14 5 2019
pubmed: 14 5 2019
medline: 14 5 2019
Statut: epublish

Résumé

B-cell lymphoproliferative disorders with renal involvement are relatively frequent, but remain poorly described. A kidney biopsy is usually required to detect the renal lesions that are often missed using other diagnostic tools. We retrospectively identified 34 patients with renal lymphoma diagnosed by percutaneous kidney biopsy (PKB) at Rennes University Hospital and its affiliated hospital centers between January 1, 2004, and May 1, 2016. Clinical, biological, radiological, and histological characteristics were collected at biopsy time. The included patients had Waldenström macroglobulinemia ( Renal involvement in the context of B-cell lymphoproliferative disorders is not uncommon. PKB is the best method to confirm this diagnosis. It should be performed early to rapidly initiate the hematological treatment to preserve kidney function.

Sections du résumé

BACKGROUND BACKGROUND
B-cell lymphoproliferative disorders with renal involvement are relatively frequent, but remain poorly described. A kidney biopsy is usually required to detect the renal lesions that are often missed using other diagnostic tools.
METHODS METHODS
We retrospectively identified 34 patients with renal lymphoma diagnosed by percutaneous kidney biopsy (PKB) at Rennes University Hospital and its affiliated hospital centers between January 1, 2004, and May 1, 2016. Clinical, biological, radiological, and histological characteristics were collected at biopsy time.
RESULTS RESULTS
The included patients had Waldenström macroglobulinemia (
CONCLUSION CONCLUSIONS
Renal involvement in the context of B-cell lymphoproliferative disorders is not uncommon. PKB is the best method to confirm this diagnosis. It should be performed early to rapidly initiate the hematological treatment to preserve kidney function.

Identifiants

pubmed: 31080924
doi: 10.1016/j.ekir.2019.02.008
pii: S2468-0249(19)30052-X
pmc: PMC6506703
doi:

Types de publication

Journal Article

Langues

eng

Pagination

688-697

Références

Kidney Int. 1999 Jul;56(1):355-77
pubmed: 10411717
Radiographics. 2000 Jan-Feb;20(1):197-212
pubmed: 10682781
Eur J Haematol. 2001 Sep;67(3):158-64
pubmed: 11737248
Lancet. 1957 Jun 8;272(6980):1162-7
pubmed: 13439992
Am J Med. 1962 Feb;32:184-207
pubmed: 14492019
Am J Kidney Dis. 2003 Nov;42(5):960-71
pubmed: 14582040
Nephrol Dial Transplant. 2004 Oct;19(10):2657-60
pubmed: 15388825
J Am Soc Nephrol. 2005 Jan;16(1):151-61
pubmed: 15574506
J Clin Oncol. 2007 Feb 10;25(5):579-86
pubmed: 17242396
Saudi Med J. 2008 Dec;29(12):1808-10
pubmed: 19082238
Hum Pathol. 2011 Jun;42(6):896-903
pubmed: 21288559
Nephrol Ther. 2011 Nov;7(6):479-87
pubmed: 21439927
Am J Kidney Dis. 2012 Dec;60(6):1044-8
pubmed: 22835902
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Clin J Am Soc Nephrol. 2012 Oct;7(10):1701-12
pubmed: 22904123
PLoS One. 2013;8(2):e55870
pubmed: 23457485
Am J Kidney Dis. 2015 Nov;66(5):756-67
pubmed: 25987261
Haematologica. 2015 Sep;100(9):1180-8
pubmed: 26088927
Haematologica. 2017 Jan;102(1):e22-e25
pubmed: 27634202
J Clin Oncol. 1989 Nov;7(11):1630-6
pubmed: 2809679
Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1037-1046
pubmed: 29848505
Am J Med. 1986 Jan;80(1):63-70
pubmed: 3510541
Radiology. 1982 Sep;144(4):759-66
pubmed: 7111721
Hum Pathol. 1981 May;12(5):432-40
pubmed: 7250955
Kidney Int. 1980 Jun;17(6):847-55
pubmed: 7412115
Leuk Lymphoma. 1994 Dec;16(1-2):37-50
pubmed: 7696930
J Surg Oncol. 1997 Mar;64(3):207-11
pubmed: 9121151
J Am Soc Nephrol. 1997 Aug;8(8):1348-54
pubmed: 9259365
Urology. 1998 Jan;51(1):3-11
pubmed: 9457281
Gen Diagn Pathol. 1998 Apr;143(5-6):317-20
pubmed: 9653914
AJR Am J Roentgenol. 1998 Oct;171(4):1067-72
pubmed: 9762998

Auteurs

Lea Corlu (L)

CHU de Rennes, Service de Néphrologie, Rennes, France.

Nathalie Rioux-Leclercq (N)

CHU de Rennes, Service d'Anatomo-cytopathologie, Rennes, France.

Michel Ganard (M)

CHU de Rennes, Service d'Hématologie, Rennes, France.

Olivier Decaux (O)

CHU de Rennes, Service de Médecine Interne, Rennes, France.

Roch Houot (R)

CHU de Rennes, Service d'Hématologie, Rennes, France.

Cécile Vigneau (C)

CHU de Rennes, Service de Néphrologie, Rennes, France.
CHU de Rennes, Service d'Anatomo-cytopathologie, Rennes, France.
CHU de Rennes, Service d'Hématologie, Rennes, France.
CHU de Rennes, Service de Médecine Interne, Rennes, France.
IRSET, Rennes, France.

Classifications MeSH